| 2024/04/24 09:17:28 | |
|---|---|
| Price | |
| 113.00 CHF | |
| Difference | 15.31% (15.00) |
General attributes
| ISIN | US98956P1021 |
| Symbol | ZBH |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 20,883 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 72.00 CHF (82) |
| Ask (Ask size) | 124.00 CHF (82) |
| Open | 113.00 CHF |
| High | 113.00 CHF |
| Low | 113.00 CHF |
| Close (prev. day) | 98.00 CHF |
| VWAP | 113.00 CHF |
| Volume (pcs) | 1 |
| Trading volume | 113.00 |
| Number of trades | 1 |
| Last size | 1 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: ZIMMER BIOMET HOLDINGS INC |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/24 09:17:28 | |
|---|---|
| Price | |
| 113.00 CHF | |
| Difference | 15.31% (15.00) |
General attributes
| ISIN | US98956P1021 |
| Symbol | ZBH |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 20,883 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 72.00 CHF (82) |
| Ask (Ask size) | 124.00 CHF (82) |
| Open | 113.00 CHF |
| High | 113.00 CHF |
| Low | 113.00 CHF |
| Close (prev. day) | 98.00 CHF |
| VWAP | 113.00 CHF |
| Volume (pcs) | 1 |
| Trading volume | 113.00 |
| Number of trades | 1 |
| Last size | 1 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | - | +2.73% | -26.55% |
| Perf (abs.) | - | +3.00 | -40.84 |
| Beta | 0.42 | 0.64 | 0.78 |
| Volatility | - | 80.57 | 81.31 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | - CHF (-) |
| Ø price 30 days | Ø volume 30 days (pcs.) | - CHF (-) |
| Ø price 100 days | Ø volume 100 days (pcs.) | - CHF (-) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 106.67 CHF (3,526) |
| YTD High | date | - CHF (-) |
| YTD Low | date | - CHF (-) |
| 52 Weeks High | date | 113.00 CHF (2024/04/24) |
| 52 Weeks Low | date | 97.00 CHF (2023/11/22) |
Arbitrage views
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Vienna Stock Exchange | 2024/07/18 | 09:05 | 101.80 EUR | 0.00 | 1 |
| Tradegate | 2024/07/17 | 22:26 | 101.55 EUR | 0.11 | 6 |
| Stuttgart | 2024/07/18 | 08:06 | 101.15 EUR | 0.00 | 1 |
| SIX Swiss Exchange | 2024/04/24 | 09:17 | 113.00 CHF | 0.00 | 1 |
| NYSE | 2024/07/17 | 22:00 | 111.05 USD | 248.47 | 34,093 |
| Munich | 2024/07/18 | 08:00 | 101.05 EUR | 0.00 | 1 |
| London Stock Exchange | 2021/01/29 | 15:41 | 136.1241 CHF | 0.00 | 1 |
| Hanover | 2024/07/18 | 08:00 | 101.15 EUR | 0.00 | 1 |
| Frankfurt | 2024/07/18 | 08:02 | 101.05 EUR | 0.00 | 2 |
| Duesseldorf | 2024/07/18 | 08:10 | 101.10 EUR | 0.00 | 1 |
| Berlin | 2024/07/18 | 08:07 | 101.10 EUR | 0.00 | 1 |
Company Logo
Contact Details
| ZIMMER BIOMET HOLDINGS INC. |
| - - |
| 345 East Main Street - 46580 Warschau |
| Telefon: +1-574-373-3333 |
| Fax: + |
| E-mail: contactus@zimmerbiomet.com |
PDF Downloads
| Company report: ZIMMER BIOMET HOLDINGS INC | |
Company Profile
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN. |
Members of Management Board
| Christopher Begley | Chairman of Board of Directors |
| Devdatt Kurdikar | Member of Board of Directors |
| Arthur Higgins | Member of Board of Directors |
| Betsy Bernard | Member of Board of Directors |
| Louis Shapiro | Member of Board of Directors |
| Maria Hilado | Member of Board of Directors |
| Michael Farrell | Member of Board of Directors |
| Robert Hagemann | Member of Board of Directors |
| Sreelakshmi Kolli | Member of Board of Directors |
| Syed Jafry | Member of Board of Directors |
| Ivan Tornos | Chairman of Managing Board |
| Angela Main | Member of Executive Committee |
| David J. Kunz | Member of Executive Committee |
| Kenneth R. Tripp | Member of Executive Committee |
| Keri P. Mattox | Member of Executive Committee |
| Lori Winkler | Member of Executive Committee |
| Rachel H. Ellingson | Member of Executive Committee |
| Sang Yi | Member of Executive Committee |
| Suketu Upadhyay | Member of Executive Committee |
| Wilfred van Zuilen | Member of Executive Committee |
| Zeeshan Tariq | Member of Executive Committee |